Search

everythinglearnresearchcommunity

for

Search:↓

The AndroCoV Clinical Scoring is a quick, accurate, and free tool for diagnosing COVID-19.

Early balding at 40 increases prostate cancer risk.

A specific genetic marker is linked to male pattern baldness in Han Chinese men.

The MPV/PC ratio can help assess disease activity in alopecia areata.

People with alopecia areata are more likely to have other immune-related conditions.

People with alopecia areata may have a higher risk of thyroid diseases.

A new model uses specific blood markers to predict if children's hair loss will return.

Non-coding RNA boosts retinoic acid production and signaling, aiding regeneration.

A scale was made to measure hair loss severity in African American women.

The study found that a specific genetic variation in the TNFα gene is significantly linked to Alopecia Areata in the Jordanian Arab population.

Machine learning can use blood tests to help predict moderate-to-severe alopecia areata.

AB+ blood group is more common in alopecia areata patients.

Urban living may increase prostate cancer risk, while early sexual activity might reduce it.

Dermatologists vary widely in testing practices for alopecia areata, often exceeding guideline recommendations.

Non-blinded assessors tend to overestimate effects in trials by about 29%.

A lower second to fourth finger length ratio may predict male alopecia areata.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

Copeptin and cortisol levels are higher in alopecia areata patients, suggesting they could help diagnose and manage the condition.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Higher inflammation markers are linked to more severe alopecia areata.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.

The document suggests that more research is needed to confirm if baldness can indicate a higher risk of severe COVID-19 in men.

The AndroCoV Clinical Scoring is an accurate, easy, and free way to diagnose COVID-19 without a lab test.

The Gabrin sign may help identify COVID-19 patients at high risk who also have hair loss due to male hormones.

Merkel cell carcinoma is most likely to recur within two years of diagnosis, and factors like immune suppression, being over 75, and male sex increase this risk.

A high neutrophil-to-lymphocyte ratio may predict poor response to hair loss treatment.

Androgen-driven traits don't predict prostate cancer recurrence.

The trichometer is a quick and reliable tool for measuring hair quantity.